Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-036416
Filing Date
2013-07-12
Accepted
2013-07-12 15:11:51
Documents
1
Period of Report
2013-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10811
  Complete submission text file 0001209191-13-036416.txt   13560
Mailing Address 530 FAIRVIEW AVENUE NORTH SUITE 2000 SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SUITE 2000 SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Issuer) CIK: 0001401708 (see all company filings)

EIN.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Ventures II, LLC (Reporting) CIK: 0001431437 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35980 | Film No.: 13965877

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Ventures II GP, L.P. (Reporting) CIK: 0001431439 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35980 | Film No.: 13965878

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences II, L.P. (Reporting) CIK: 0001431443 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35980 | Film No.: 13965879